Clinical Trial Update: LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids [Phase 3]

View source ↗

Summary

Results from the LIBERTY EXTENSION, a Phase 3 extension study of relugolix in women with heavy menstrual bleeding due to uterine fibroids, evaluating ongoing ef…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menorrhagia
• Uterine Fibroids

Drugs mentioned

• Relugolix (Relugolix)

Snippet

Sponsor: Myovant Sciences GmbH | Conditions: Heavy Menstrual Bleeding, Uterine Fibroid | Phase 3 | Status: COMPLETED | Results posted: 2024-05-09